|
|
Reimagining
the Future
How
Together Industry and Regulators Can Change the Clinical Trial
Paradigm
"'We
hear from patients that participating in clinical trials places
enormous demands on them. For many, participation could take up
to a week out of their life as well as their caregivers.
Considering that patients will have to do this a few times a
year, it places a huge burden on them and their family,' says
Peter Bergethon, Vice President and Head of Digital and
Quantitative Medicine at Biogen.
... A
digital trial recognizes these components and decentralizes
several activities thus removing the burden of travel on the
patient and their families. Additionally, doing things remotely
could potentially mean reaching more patients, something that
would be particularly important with rare diseases. Ultimately
this could mean getting to a potential treatment faster.
'Decentralizing
clinical trials and moving to digital is by no means a novel
idea. As an industry we have been using digital technologies to
collect data for some time. And we have made some headway,
especially in clinic,' says Peter."
|
|
|
For more
information on digital clinical trials, check out the Research
and Resources section at the end of this newsletter.
|
|
|
Caring for Latino Patients and Families During
COVID-19
"As
we approach the one-year anniversary of the COVID-19 pandemic
in the United States, Latinos – also referred to as
Hispanic or Latinx populations – remain among the hardest
hit. Since some of the earliest outbreaks in food
production workplaces, Latinos have comprised
33% of COVID-19 cases as of December 2020 (despite
accounting for 18.5% of the population); been
hospitalized at 4x the rate of White Americans; and
experienced greater case outbreak severity and death rates
in nursing homes."
I
Read
on to understand this disproportionate impact.
I
From:
CAPC Blog | January 8, 2021
|
|
|
|
|
Prioritizing Family Caregivers for the COVID
Vaccine
This
op-ed was written by a family caregiver, Maggie Ornstein.
"Family
caregivers are direct care workers. We are essential workers.
We are unpaid home care workers doing the same job as hospital
and nursing home staff, but without pay, labor protections or
other benefits. If we aren’t protected, many of those we care
for could end up in nursing homes, where 40 percent of COVID-19
deaths nationwide have occurred and where care is costly,
placing an additional and intense burden on an already strained
health care system. Protecting family caregivers, along with
those they care for, is good public health.
From:
CityLimits | January 20, 2021
|
|
|
|
|
|
Mental
Illness Caregiving
|
|
|
As many
as 27 percent of caregivers of adults over the age of 18 are
providing care to an adult with an emotional or mental health
issue (according to research from NAC and AARP's Caregiving
in the U.S. 2020). As some have said, mental
illness is a disease that affects the whole family. Family
caregivers feel the impact of the disease as they struggle to
care for their loved ones and to bridge health care systems,
mental health providers, and community supports.
In
February 2016, The National Alliance for Caregiving, in
partnership with Mental
Health America and the National
Alliance on Mental Illness
released a study on the obstacles and opportunities facing caregivers
of adults with mental illness. The study, On
Pins & Needles: Caregivers of Adults with Mental Illness, identified
startling inadequacies in the U.S. health care system in meeting
the needs of families who manage moderate-to-serious mental
illness.
|
|
|
To
support caregivers of individuals managing a mental illness, the
National Alliance for Caregiving and the National Alliance on
Mental Illness developed Circle
of Care: A Guidebook for Mental Health Caregivers. The
guidebook emerged from the national study on mental health
caregiving and was designed to guide unpaid friends, family, and
neighbors who care for someone with a mental health condition.
The fact sheets are intended to assist these caregivers with
finding help for the specific challenges identified in
the On Pins and Needles study.
Click
the red link below to check
out the
guidebook.
|
|
|
What’s Next Longevity Innovation Summit
March 1, 2021 | Washington, D.C. | Virtual
Position
your company as a leader in the longevity market, make
connections with leaders in this space, and gain a unique
perspective on how five generations are impacted by an aging
population.
|
|
|
Challenges
of Aging During COVID-19: Long-Term Care, Vaccination, and
Isolation
January 15, 2021 | Online
Since
the beginning of the pandemic, the danger COVID-19 poses to older
adults and people living in long-term care facilities has been of
great concern. COVID-19 has claimed the lives of more than 125,000 long-term
care residents and staff and 8
out of 10 COVID-19 deaths reported have been among
adults aged 65 and older. Now with two authorized vaccines and
the CDC recommendation
of older adults for early vaccine access, there is hope, but
there are still challenges with distribution. It is also
necessary to address the pandemic’s mental health impact on older
adults, particularly loneliness and isolation. While older adults
have reported less
loneliness than their younger counterparts during the
pandemic, about one
in four report anxiety or depression due to the
pandemic. Speakers discussed:
· Overview
of COVID-19’s challenges to long-term care and the future
implications for nursing homes
· Vaccination
and vaccine distribution challenges for older adults
· A health
plan’s efforts to address pandemic isolation and loneliness
|
|
|
Early
Lessons from the COVID-19 Vaccine Rollout to High Priority
Populations
January 14, 2021 | Online
KFF held an
interactive web event on Thursday, January 14 to provide the
latest data on COVID-19 cases and deaths in long-term care
facilities and examine how the effort to vaccinate residents and
staff in long-term care settings is going, challenges experienced
so far, and opportunities for improvement.
|
|
|
Apply to Be a Health and Aging Policy Fellow
Deadline: April 15, 2021
Candidates
with a strong commitment to health and aging issues, leadership
potential, and interest in aging-relevant policy work are invited
to join the next class of Health and Aging Policy Fellows
(2021-2022).
The
Health and Aging Policy Fellows Program continues to make great
strides in advancing policy with creative solutions in the
context of COVID-19.
|
|
|
ARCH Seeking to Recognize Respite Innovation &
Quality
Deadline: March 1, 2021
If your
respite service addresses critical respite needs for any
population in your community and can demonstrate innovation and
quality worthy of replication, you can apply for recognition as
an ARCH Innovative and
Exemplary Respite Service.
If
selected, your services will be recognized as a potential model
for replication!
|
|
|
U.S. NAM
Catalyst Award Competition Round 2 (2021)
Deadline:
March 8, 2021
As part
of the Healthy
Longevity Global Competition, the
U.S. National Academy of Medicine (“NAM”), with support from
Johnson & Johnson Innovation, will issue up to 24 Catalyst
Awards per year, in three annual rounds (i.e., in 2020, 2021, and
2022). Each Catalyst Award includes a $50,000 cash prize as well
as travel costs to attend an annual Innovator Summit.
There
will be one application period per year. The current request for
applications is for Round 2 of the NAM Catalyst Awards. The
application period opens on January 25, 2021 and closes on March
8, 2021.
Catalyst
Awards will reward bold, new, potentially transformative
ideas to improve the physical, mental, or social well-being
and health of people as they age, in a measurable and equitable
way.
Click
the red link below to learn more and apply.
|
|
|
Biogen:
Transforming the Regulatory Landscape for Digital Health
Technologies in Drug Development
|
|
|
This white paper from Biogen
summarizes the value of digital health technologies (DHTs) in
drug development and proposes several solutions to achieving a
modernized regulatory approach that harnesses the full potential
of these innovative technologies.
According to this paper, DHTs are effective in
increasing access to clinical trials through cost reduction and
improvement in caregiver and patient convenience.
|
|
|
FOLLOW US
TO STAY CURRENT ON CAREGIVING!
|
|
|
|
|
|
|
